![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
SIRIO Group’s global Nutra-Innovation Team is rapidly intensifying efforts to create new formulations in different delivery formats for mood and stress relief. The team’s focus follows a year of global lockdowns in which consumers faced significant challenges. This has led to a rise in demand for products that enhance personal health and wellness – mind and body – with formulations that boost mood and reduce stress in strong demand.
The Nutra-Innovation Team is part of SIRIO’s commitment to innovation and cross-functional collaboration. The team, consisting of scientists and industry experts across North America, Europe and China, works together on developing solutions around emerging trends. This allows brands to respond quickly without compromising on quality.
“Having a global team gives us insights into industry trends worldwide. In the US, Ashwagandha, a traditional Ayurvedic herb shown to help relieve stress and support relaxation, is a leader in the category of stress management”, commented Karla Acevedo, Marketing Manager – Americas at SIRIO Pharma. SIRIO has developed several formulations with this key ingredient.
In Europe, the Nutra-Innovation Team has identified hops, saffron, lavender and hempseed oil as rising stars – ingredients that help support focus, mood and calm, and meet the growing consumer demand for natural, plant-based products. In fact, SIRIO Europe will be introducing new softgel products with these ingredients by the summer of 2021.
“SIRIO is dedicated to the research and development of novel products. We work on identifying key consumer health categories and introducing innovative product solutions for our customers using new or existing ingredients that have been studied for safety and efficacy – stress and mood are very popular categories right now”, commented Dominique Baum, PhD, Managing Director of SIRIO Europe.
In China, the Nutra-Innovation Team is developing a line of gummy products using new gummy technologies. The line features gummy products that combine an attractive appearance and scientific design. For example, the team has developed a center-filled, plant-based and sugar-free gummy product that promotes relaxation and calm before sleep. The main active ingredients are GABA (γ-aminobutyric acid) and theanine. The flavor profile of the product is scientifically designed – peach and oolong tea in the filling and jasmine and lavender in the outer layer. This leads to a multidimensional experience for consumers.
The Nutra-Innovation Team will continue its efforts to provide customers with high-quality, clean label options in this growing consumer segment. The company encourages nutra brands to contact SIRIO for custom supplement solutions.
About SIRIO
Founded in 1993, SIRIO Pharma Co., Ltd (SIRIO) is the leading global nutraceutical CDMO specialized in developing and manufacturing quality products including softgels, capsules, tablets, powders, gummies, functional beverages, probiotics and other dosage forms. The company has extensive capabilities with multiple manufacturing sites in China, as well as manufacturing facilities in Europe and marketing teams in the USA. SIRIO offers a variety of solutions including product development, manufacturing, packaging and logistics to its customers.
SIRIO is approved by TGA-GMP, NPA/UL GMP, BRC, UL’s Management System 21 CFR Part 111, ISO 9001:2015 certification, and etc. Cooperating with many well-known nutraceutical companies, SIRIO is committed to providing products and service to customers all around the world
